PHF23
gene geneOn this page
Also known as MGC2941FLJ16355
Summary
PHF23 (PHD finger protein 23, HGNC:28428) is a protein-coding gene on chromosome 17p13.1, encoding PHD finger protein 23 (Q9BUL5). Acts as a negative regulator of autophagy, through promoting ubiquitination and degradation of LRSAM1, an E3 ubiquitin ligase that promotes autophagy in response to starvation or infecting bacteria.
Predicted to enable zinc ion binding activity. Involved in negative regulation of autophagosome assembly; negative regulation of autophagosome maturation; and positive regulation of protein ubiquitination. Located in cytosol and nucleoplasm.
Source: NCBI Gene 79142 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 66 total
- Druggable target: yes
- MANE Select transcript:
NM_024297
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28428 |
| Approved symbol | PHF23 |
| Name | PHD finger protein 23 |
| Location | 17p13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC2941, FLJ16355 |
| Ensembl gene | ENSG00000040633 |
| Ensembl biotype | protein_coding |
| OMIM | 612910 |
| Entrez | 79142 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 11 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000320316, ENST00000454255, ENST00000570753, ENST00000570899, ENST00000571362, ENST00000572789, ENST00000573826, ENST00000574236, ENST00000574323, ENST00000574407, ENST00000574899, ENST00000576955, ENST00000613632
RefSeq mRNA: 3 — MANE Select: NM_024297
NM_001284517, NM_001284518, NM_024297
CCDS: CCDS42250, CCDS67143, CCDS67144
Canonical transcript exons
ENST00000320316 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001117798 | 7239246 | 7239457 |
| ENSE00002631934 | 7235038 | 7235840 |
| ENSE00003512596 | 7235930 | 7236767 |
| ENSE00003545159 | 7237629 | 7237660 |
| ENSE00003625323 | 7237385 | 7237477 |
Expression profiles
Bgee: expression breadth ubiquitous, 247 present calls, max score 93.82.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.7621 / max 81.4095, expressed in 1790 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 164159 | 10.1953 | 1775 |
| 164158 | 1.3384 | 918 |
| 164157 | 0.2283 | 77 |
Top tissues by expression
254 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 93.82 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 93.75 | gold quality |
| right adrenal gland | UBERON:0001233 | 93.50 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 92.99 | gold quality |
| stromal cell of endometrium | CL:0002255 | 92.96 | gold quality |
| left adrenal gland | UBERON:0001234 | 92.55 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 92.42 | gold quality |
| blood | UBERON:0000178 | 92.32 | gold quality |
| adrenal cortex | UBERON:0001235 | 92.01 | gold quality |
| adrenal gland | UBERON:0002369 | 91.93 | gold quality |
| islet of Langerhans | UBERON:0000006 | 91.05 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 90.97 | gold quality |
| ventricular zone | UBERON:0003053 | 90.67 | gold quality |
| esophagus mucosa | UBERON:0002469 | 90.62 | gold quality |
| ganglionic eminence | UBERON:0004023 | 90.24 | gold quality |
| cortical plate | UBERON:0005343 | 90.05 | gold quality |
| adrenal tissue | UBERON:0018303 | 89.98 | gold quality |
| vermiform appendix | UBERON:0001154 | 89.61 | gold quality |
| esophagus | UBERON:0001043 | 89.54 | gold quality |
| lymph node | UBERON:0000029 | 89.50 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 89.15 | gold quality |
| prefrontal cortex | UBERON:0000451 | 89.14 | gold quality |
| gall bladder | UBERON:0002110 | 88.98 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 88.49 | gold quality |
| leukocyte | CL:0000738 | 88.46 | gold quality |
| spleen | UBERON:0002106 | 88.43 | gold quality |
| lower esophagus | UBERON:0013473 | 88.32 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 88.29 | gold quality |
| metanephros | UBERON:0000081 | 88.21 | gold quality |
| ileal mucosa | UBERON:0000331 | 88.19 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.82 |
| E-MTAB-7052 | no | 66.13 |
| E-HCAD-13 | no | 3.03 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
52 targeting PHF23, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-3667-3P | 99.99 | 67.17 | 1636 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-3150A-3P | 99.76 | 64.44 | 1640 |
| HSA-MIR-6763-5P | 99.76 | 64.68 | 1767 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-4699-3P | 99.71 | 70.15 | 3142 |
Literature-anchored findings (GeneRIF, showing 3)
- Plant homeodomain finger protein 23 negatively regulates cell autophagy by promoting ubiquitination and degradation of E3 ligase LRSAM1 (PMID:25484098)
- Mechanistic insights into chromatin targeting by leukemic NUP98-PHF23 fusion. (PMID:32620764)
- PHF23 promotes NSCLC proliferation, metastasis, and chemoresistance via stabilization of ACTN4 and activation of the ERK pathway. (PMID:37626047)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | phf23a | ENSDARG00000030887 |
| danio_rerio | phf23b | ENSDARG00000036305 |
| mus_musculus | Phf23 | ENSMUSG00000018572 |
| rattus_norvegicus | Phf23 | ENSRNOG00000017657 |
Paralogs (1): PHF13 (ENSG00000116273)
Protein
Protein identifiers
PHD finger protein 23 — Q9BUL5 (reviewed: Q9BUL5)
Alternative names: PDH-containing protein JUNE-1
All UniProt accessions (8): A0A087WVQ2, I3L0X3, I3L0Y2, I3L1N0, I3L2W6, I3L410, I3L4Q4, Q9BUL5
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a negative regulator of autophagy, through promoting ubiquitination and degradation of LRSAM1, an E3 ubiquitin ligase that promotes autophagy in response to starvation or infecting bacteria.
Subunit / interactions. Interacts with LRSAM1.
Subcellular location. Nucleus. Cytoplasm.
Tissue specificity. Widely expressed in human tissues and various cell lines.
Disease relevance. A chromosomal aberration involving PHF23 is found in a patient with acute myeloid leukemia (AML). Translocation t(11;17)(p15;p13) with NUP98.
Domain organisation. The PHD-type zinc-finger domain is required for interaction with LRSAM1 and negative regulation of autophagy.
Similarity. Belongs to the PHF23 family.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9BUL5-1 | 1 | yes |
| Q9BUL5-2 | 2, JUNE1B | |
| Q9BUL5-3 | 3 | |
| Q9BUL5-4 | 4 |
RefSeq proteins (3): NP_001271446, NP_001271447, NP_077273* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001965 | Znf_PHD | Domain |
| IPR011011 | Znf_FYVE_PHD | Homologous_superfamily |
| IPR013083 | Znf_RING/FYVE/PHD | Homologous_superfamily |
| IPR019787 | Znf_PHD-finger | Domain |
Pfam: PF13831
UniProt features (33 total): modified residue 9, compositionally biased region 8, splice variant 4, region of interest 3, turn 3, strand 2, chain 1, zinc finger region 1, site 1, sequence conflict 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6WXK | X-RAY DIFFRACTION | 2.9 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BUL5-F1 | 61.11 | 0.16 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 120–121 (breakpoint for translocation to form nup98-phf23 oncogene)
Post-translational modifications (9): 1, 124, 147, 150, 165, 315, 316, 317, 400
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 200 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN, GOBP_REGULATION_OF_AUTOPHAGY, PAX4_01, GOBP_VACUOLE_ORGANIZATION, LFA1_Q6, GCAAGGA_MIR502, AACYNNNNTTCCS_UNKNOWN, AP4_Q6, GOBP_REGULATION_OF_VACUOLE_ORGANIZATION, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GGGTGGRR_PAX4_03, CAGCTG_AP4_Q5, SP1_Q2_01, GOBP_NEGATIVE_REGULATION_OF_ORGANELLE_ASSEMBLY, GOBP_MACROAUTOPHAGY
GO Biological Process (4): autophagy (GO:0006914), positive regulation of protein ubiquitination (GO:0031398), negative regulation of autophagosome maturation (GO:1901097), negative regulation of autophagosome assembly (GO:1902902)
GO Molecular Function (3): zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (4): nucleus (GO:0005634), nucleoplasm (GO:0005654), cytosol (GO:0005829), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| negative regulation of macroautophagy | 2 |
| catabolic process | 1 |
| transmembrane transport | 1 |
| process utilizing autophagic mechanism | 1 |
| protein ubiquitination | 1 |
| regulation of protein ubiquitination | 1 |
| positive regulation of protein modification by small protein conjugation or removal | 1 |
| negative regulation of protein-containing complex disassembly | 1 |
| autophagosome maturation | 1 |
| regulation of autophagosome maturation | 1 |
| autophagosome assembly | 1 |
| negative regulation of organelle assembly | 1 |
| regulation of autophagosome assembly | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
1324 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PHF23 | NUP98 | P52948 | 917 |
| PHF23 | KDM5A | P29375 | 859 |
| PHF23 | NSD1 | Q96L73 | 725 |
| PHF23 | MEIS1 | O00470 | 695 |
| PHF23 | DDX10 | Q13206 | 689 |
| PHF23 | PSIP1 | O75475 | 676 |
| PHF23 | HOXD13 | P35453 | 641 |
| PHF23 | NSD3 | Q9BZ95 | 636 |
| PHF23 | H3C1 | P02295 | 631 |
| PHF23 | H3-5 | Q6NXT2 | 631 |
| PHF23 | H3-3A | P06351 | 628 |
| PHF23 | H3-4 | Q16695 | 628 |
| PHF23 | H3-7 | Q5TEC6 | 628 |
| PHF23 | H3C14 | Q71DI3 | 628 |
| PHF23 | HOXA9 | P31269 | 600 |
IntAct
41 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FOXK2 | DVL2 | psi-mi:“MI:0914”(association) | 0.640 |
| CASP6 | PHF23 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PHF23 | FGFR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PHF23 | GSN | psi-mi:“MI:0915”(physical association) | 0.560 |
| PHF23 | HRAS | psi-mi:“MI:0915”(physical association) | 0.560 |
| LAMP2 | PHF23 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RAN | PHF23 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KLF11 | PHF23 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PHF23 | CYCS | psi-mi:“MI:0915”(physical association) | 0.560 |
| HCCS | NPAT | psi-mi:“MI:0914”(association) | 0.530 |
| PHF23 | ERBB2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PHF23 | STK11 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PHF23 | SIN3B | psi-mi:“MI:0914”(association) | 0.350 |
| HCCS | MPZL1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (57): PHF23 (Affinity Capture-MS), LRSAM1 (Affinity Capture-Western), PHF23 (Affinity Capture-Western), LRSAM1 (Reconstituted Complex), PHF23 (Two-hybrid), PHF23 (Two-hybrid), PHF23 (Affinity Capture-MS), PHF23 (Affinity Capture-MS), SIN3A (Affinity Capture-MS), SAP130 (Affinity Capture-MS), ARID4B (Affinity Capture-MS), SIN3B (Affinity Capture-MS), SAP30 (Affinity Capture-MS), SUDS3 (Affinity Capture-MS), BRMS1L (Affinity Capture-MS)
ESM2 similar proteins: A0A8I5ZM56, A2AG50, A2AI08, A2AJI0, A5D7K1, D4A4L4, E1C2Q8, F1LR10, O00515, O14529, O75128, O88573, O88735, P51825, P57016, Q14244, Q32LQ1, Q3KQU3, Q3U2K0, Q5JTD0, Q5PR69, Q5R7F9, Q5XHX2, Q5ZIA2, Q5ZJJ1, Q68DK7, Q6IPM2, Q6NV74, Q6NZF1, Q6P9J5, Q6PDH0, Q6PDM1, Q6PG95, Q6ZU35, Q86UU1, Q8CCJ4, Q8K124, Q8N7J2, Q8TD55, Q96PV7
Diamond homologs: A5D962, Q0IHB0, Q5BJ10, Q5HZN9, Q5U5E5, Q6AY75, Q7SXB5, Q86YI8, Q8BSN5, Q8K2W6, Q9BUL5, Q08D35, O75151, Q8BLG0, Q9BVI0, Q9FEN9, Q9WTU0, O44498, Q9U263
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
66 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 56 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
960 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:7235929:C:CG | donor_loss | 1.0000 |
| 17:7236763:CTTTC:C | acceptor_gain | 1.0000 |
| 17:7236767:CCT:C | acceptor_gain | 1.0000 |
| 17:7236769:T:C | acceptor_gain | 1.0000 |
| 17:7236769:T:TC | acceptor_gain | 1.0000 |
| 17:7237384:CCT:C | donor_gain | 1.0000 |
| 17:7237427:A:C | donor_gain | 1.0000 |
| 17:7237478:C:CC | acceptor_gain | 1.0000 |
| 17:7237625:TCAC:T | donor_loss | 1.0000 |
| 17:7237626:CAC:C | donor_loss | 1.0000 |
| 17:7237627:AC:A | donor_loss | 1.0000 |
| 17:7237661:C:CC | acceptor_gain | 1.0000 |
| 17:7236655:A:C | donor_gain | 0.9900 |
| 17:7236768:C:CC | acceptor_gain | 0.9900 |
| 17:7236768:C:T | acceptor_gain | 0.9900 |
| 17:7237379:CCCTA:C | donor_loss | 0.9900 |
| 17:7237380:CCTA:C | donor_loss | 0.9900 |
| 17:7237381:CTAC:C | donor_loss | 0.9900 |
| 17:7237382:TA:T | donor_loss | 0.9900 |
| 17:7237383:A:C | donor_loss | 0.9900 |
| 17:7237384:CC:C | donor_loss | 0.9900 |
| 17:7237474:GTGG:G | acceptor_gain | 0.9900 |
| 17:7237475:TGG:T | acceptor_gain | 0.9900 |
| 17:7237475:TGGC:T | acceptor_loss | 0.9900 |
| 17:7237476:GG:G | acceptor_gain | 0.9900 |
| 17:7237477:GC:G | acceptor_loss | 0.9900 |
| 17:7237479:T:C | acceptor_loss | 0.9900 |
| 17:7237659:ATCTG:A | acceptor_loss | 0.9900 |
| 17:7237660:TCT:T | acceptor_loss | 0.9900 |
| 17:7237661:C:A | acceptor_loss | 0.9900 |
AlphaMissense
2610 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:7235686:G:C | C384W | 1.000 |
| 17:7235687:C:G | C384S | 1.000 |
| 17:7235687:C:T | C384Y | 1.000 |
| 17:7235688:A:G | C384R | 1.000 |
| 17:7235688:A:T | C384S | 1.000 |
| 17:7235695:G:C | C381W | 1.000 |
| 17:7235696:C:A | C381F | 1.000 |
| 17:7235696:C:G | C381S | 1.000 |
| 17:7235696:C:T | C381Y | 1.000 |
| 17:7235697:A:G | C381R | 1.000 |
| 17:7235697:A:T | C381S | 1.000 |
| 17:7235701:A:C | F379L | 1.000 |
| 17:7235701:A:T | F379L | 1.000 |
| 17:7235702:A:C | F379C | 1.000 |
| 17:7235702:A:G | F379S | 1.000 |
| 17:7235703:A:G | F379L | 1.000 |
| 17:7235711:G:T | P376H | 1.000 |
| 17:7235712:G:A | P376S | 1.000 |
| 17:7235714:A:T | V375D | 1.000 |
| 17:7235725:C:A | K371N | 1.000 |
| 17:7235725:C:G | K371N | 1.000 |
| 17:7235729:A:C | I370S | 1.000 |
| 17:7235729:A:G | I370T | 1.000 |
| 17:7235729:A:T | I370N | 1.000 |
| 17:7235735:G:T | A368D | 1.000 |
| 17:7235737:A:C | C367W | 1.000 |
| 17:7235738:C:A | C367F | 1.000 |
| 17:7235738:C:G | C367S | 1.000 |
| 17:7235738:C:T | C367Y | 1.000 |
| 17:7235739:A:C | C367G | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000459012 (17:7240108 A>C,G), RS1000557803 (17:7240386 G>A), RS1000598225 (17:7235015 G>A,C), RS1000676156 (17:7234567 C>T), RS1002182880 (17:7241521 C>T), RS1002226595 (17:7236423 G>A,T), RS1002232858 (17:7237790 G>A,C), RS1002279024 (17:7236842 A>C), RS1003310370 (17:7242394 C>G), RS1004287789 (17:7239848 C>G), RS1004320392 (17:7240735 A>G), RS1004599170 (17:7234744 C>T), RS1004782423 (17:7234627 T>A,C,G), RS1006317345 (17:7237828 C>A,G,T), RS1006399553 (17:7235557 C>A)
Disease associations
OMIM: gene MIM:612910 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002388_485 | Lymphocyte count | 2.000000e-17 |
| GCST90002389_221 | Lymphocyte percentage of white cells | 5.000000e-19 |
| GCST90002399_280 | Neutrophil percentage of white cells | 9.000000e-12 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004587 | lymphocyte count |
| EFO:0007993 | lymphocyte percentage of leukocytes |
| EFO:0007990 | neutrophil percentage of leukocytes |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL2424508 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
35 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression | 4 |
| trichostatin A | affects expression, decreases expression | 2 |
| Formaldehyde | decreases expression | 2 |
| Lead | affects expression, affects methylation | 2 |
| Cyclosporine | decreases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| FR900359 | affects phosphorylation | 1 |
| TAK-243 | decreases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| beta-lapachone | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| coumarin | affects phosphorylation | 1 |
| beta-methylcholine | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants, Occupational | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Atrazine | decreases expression | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Methotrexate | decreases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Nickel | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
ChEMBL screening assays
3 unique, capped per target: 3 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL2429071 | Binding | Inhibition of PHF23 (unknown origin) after 30 mins by AlphaScreen assay | Small-molecule ligands of methyl-lysine binding proteins: optimization of selectivity for L3MBTL3. — J Med Chem |
Cellosaurus cell lines
2 cell lines: 2 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B3DS | Abcam HEK293T PHF23 KO | Transformed cell line | Female |
| CVCL_E1FS | Abcam HEK293 PHF23 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.